24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Sisram Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:00
Decart launches real-time AI tool for live video transformation
21:27
Full list of Israeli high-tech layoffs in 2025
21:24
$205M-backed TytoCare cuts 20% of staff, CEO Gilad to transition to chairman role
20:42
Qwilt CEO quits as $134M-backed startup considers mergers
More stories
Buzz
Most popular
Daily
Weekly
1
Israel orders more Arrow 3 missiles, rushes Arrow 4 to meet hypersonic threats
2
Oracle CEO: "Some of the best people in the world are here in Israel, and there's no question about that"
3
AT&T buys $650M stake in DriveNets, delivering major payout to founders, employees and early backers
4
Mapping Israel’s $20B GenAI boom: 342 startups and counting
5
Underground mapping startup Exodigo raises $96M, hits $700M valuation
More news
Sisram Medical
5 stories about Sisram Medical
Fosun Whetted Our Appetite, Says Alma Lasers CEO
04.07.19
|
Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
Fosun Pharma Inaugurates New Building for Israeli Subsidiary Sisram Medical
26.02.19
|
Golan Hazani
Fosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017
Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea
10.12.18
|
Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
Sisram Stock Price Down on Market Debut
19.09.17
|
Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO
10.09.17
|
Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange